Erythromycin (specifically, erythromycin stearate)
Nausea, vomiting, abdominal discomfort, diarrhea, antibiotic-associated colitis, urticaria, rashes, and other allergic reactions. Reversible hearing loss after large doses.
Hypersensitivity to erythromycin, existing liver dysfunction, or concurrent use of potentially hepatotoxic drugs.
Adults and children over 8 years: 250-500 mg every 6 hours or 0.5-1 g every 12 hours; up to 4 g daily in severe infections. Children up to 2 years: 125 mg every 6 hours. Children 2-8 years: 250 mg every 6 hours. Doses may be doubled for severe infections in children.
Below 30°C, protected from light and moisture.
36 months from the date of manufacture.
Oral infections, campylobacter enteritis, syphilis, non-gonococcal urethritis, respiratory tract infections (including Legionnaires' disease), skin infections, chronic prostatitis, diphtheria and whooping cough prophylaxis, acne vulgaris, and rosacea.
Caution should be exercised, and dosage adjustments may be necessary.
Yes, with carbamazepine, cyclosporine, theophylline, warfarin, digoxin, penicillins, terfenadine, and astemizole.
Alu/Alu strips of 10 tablets, ten strips per carton, packed into a corrugated box.
Globela Pharma Pvt. Ltd. for Everdestiny Pharmaceuticals Ltd.
Cholestatic jaundice, infantile hypertrophic pyloric stenosis, cardiac effects (chest pain and arrhythmias), myasthenia-like syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis.
Not known to be harmful during pregnancy; small amounts excreted in breast milk.
An alternative to penicillin in patients with penicillin hypersensitivity.